Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

ΔNp63α stops TAp73β from working in skin cancer by blocking its access to specific genes, not by directly interacting with it.

New laser particles can track thousands of cells in 3D models, improving single-cell analysis.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

LPR1 regulates root growth under low phosphate stress independently of SIZ1 in Arabidopsis thaliana.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Involucrin gene expression is controlled by specific proteins and signaling pathways.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

LPA 4 helps control blood and lymph vessel development in zebrafish.

Early and accurate diagnosis is crucial for managing rare genetic disorders like this localized variant of junctional epidermolysis bullosa.